Angelini Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ANGELINI PHARMA, and when can generic versions of ANGELINI PHARMA drugs launch?
ANGELINI PHARMA has one approved drug.
There are two US patents protecting ANGELINI PHARMA drugs.
There are sixty-nine patent family members on ANGELINI PHARMA drugs in thirty countries.
Summary for Angelini Pharma
| International Patents: | 69 |
| US Patents: | 2 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Angelini Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Angelini Pharma | OLEPTRO | trazodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022411-002 | Feb 2, 2010 | DISCN | Yes | No | 8,133,893 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | ||
| Angelini Pharma | OLEPTRO | trazodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022411-001 | Feb 2, 2010 | DISCN | Yes | No | 7,829,120 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Angelini Pharma | OLEPTRO | trazodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022411-002 | Feb 2, 2010 | DISCN | Yes | No | 7,829,120 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Angelini Pharma | OLEPTRO | trazodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022411-001 | Feb 2, 2010 | DISCN | Yes | No | 8,133,893 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Angelini Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Angelini Pharma | OLEPTRO | trazodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022411-001 | Feb 2, 2010 | 6,607,748 | ⤷ Subscribe |
| Angelini Pharma | OLEPTRO | trazodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022411-002 | Feb 2, 2010 | 6,607,748 | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ANGELINI PHARMA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Tablets | 150 mg and 300 mg | ➤ Subscribe | 2010-10-18 |
International Patents for Angelini Pharma Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2616416 | ⤷ Subscribe |
| Mexico | 2010001094 | ⤷ Subscribe |
| Eurasian Patent Organization | 017019 | ⤷ Subscribe |
| Canada | 2693095 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
